In line with this finding, our IHC assay in patient samples (n = 46), validated by data mining analysis, indicates that PAK1 is positively associated with HER-2 expression in GEJ adenocarcinoma. The gene discussed is ERBB2; the disease is gastroesophageal junction adenocarcinoma.